1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Attenuated Vaccine Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Attenuated Vaccine by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Attenuated Vaccine by Country/Region, 2020, 2024 & 2031 2.2 Attenuated Vaccine Segment by Type 2.2.1 Bacterial Vaccine 2.2.2 Viral Vaccine 2.3 Attenuated Vaccine Sales by Type 2.3.1 Global Attenuated Vaccine Sales Market Share by Type (2020-2025) 2.3.2 Global Attenuated Vaccine Revenue and Market Share by Type (2020-2025) 2.3.3 Global Attenuated Vaccine Sale Price by Type (2020-2025) 2.4 Attenuated Vaccine Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Others 2.5 Attenuated Vaccine Sales by Application 2.5.1 Global Attenuated Vaccine Sale Market Share by Application (2020-2025) 2.5.2 Global Attenuated Vaccine Revenue and Market Share by Application (2020-2025) 2.5.3 Global Attenuated Vaccine Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Attenuated Vaccine Breakdown Data by Company 3.1.1 Global Attenuated Vaccine Annual Sales by Company (2020-2025) 3.1.2 Global Attenuated Vaccine Sales Market Share by Company (2020-2025) 3.2 Global Attenuated Vaccine Annual Revenue by Company (2020-2025) 3.2.1 Global Attenuated Vaccine Revenue by Company (2020-2025) 3.2.2 Global Attenuated Vaccine Revenue Market Share by Company (2020-2025) 3.3 Global Attenuated Vaccine Sale Price by Company 3.4 Key Manufacturers Attenuated Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Attenuated Vaccine Product Location Distribution 3.4.2 Players Attenuated Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Attenuated Vaccine by Geographic Region 4.1 World Historic Attenuated Vaccine Market Size by Geographic Region (2020-2025) 4.1.1 Global Attenuated Vaccine Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Attenuated Vaccine Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Attenuated Vaccine Market Size by Country/Region (2020-2025) 4.2.1 Global Attenuated Vaccine Annual Sales by Country/Region (2020-2025) 4.2.2 Global Attenuated Vaccine Annual Revenue by Country/Region (2020-2025) 4.3 Americas Attenuated Vaccine Sales Growth 4.4 APAC Attenuated Vaccine Sales Growth 4.5 Europe Attenuated Vaccine Sales Growth 4.6 Middle East & Africa Attenuated Vaccine Sales Growth 5 Americas 5.1 Americas Attenuated Vaccine Sales by Country 5.1.1 Americas Attenuated Vaccine Sales by Country (2020-2025) 5.1.2 Americas Attenuated Vaccine Revenue by Country (2020-2025) 5.2 Americas Attenuated Vaccine Sales by Type (2020-2025) 5.3 Americas Attenuated Vaccine Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Attenuated Vaccine Sales by Region 6.1.1 APAC Attenuated Vaccine Sales by Region (2020-2025) 6.1.2 APAC Attenuated Vaccine Revenue by Region (2020-2025) 6.2 APAC Attenuated Vaccine Sales by Type (2020-2025) 6.3 APAC Attenuated Vaccine Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Attenuated Vaccine by Country 7.1.1 Europe Attenuated Vaccine Sales by Country (2020-2025) 7.1.2 Europe Attenuated Vaccine Revenue by Country (2020-2025) 7.2 Europe Attenuated Vaccine Sales by Type (2020-2025) 7.3 Europe Attenuated Vaccine Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Attenuated Vaccine by Country 8.1.1 Middle East & Africa Attenuated Vaccine Sales by Country (2020-2025) 8.1.2 Middle East & Africa Attenuated Vaccine Revenue by Country (2020-2025) 8.2 Middle East & Africa Attenuated Vaccine Sales by Type (2020-2025) 8.3 Middle East & Africa Attenuated Vaccine Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Attenuated Vaccine 10.3 Manufacturing Process Analysis of Attenuated Vaccine 10.4 Industry Chain Structure of Attenuated Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Attenuated Vaccine Distributors 11.3 Attenuated Vaccine Customer 12 World Forecast Review for Attenuated Vaccine by Geographic Region 12.1 Global Attenuated Vaccine Market Size Forecast by Region 12.1.1 Global Attenuated Vaccine Forecast by Region (2026-2031) 12.1.2 Global Attenuated Vaccine Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Attenuated Vaccine Forecast by Type (2026-2031) 12.7 Global Attenuated Vaccine Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Merck & Co. 13.1.1 Merck & Co. Company Information 13.1.2 Merck & Co. Attenuated Vaccine Product Portfolios and Specifications 13.1.3 Merck & Co. Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Merck & Co. Main Business Overview 13.1.5 Merck & Co. Latest Developments 13.2 GlaxoSmithKline plc 13.2.1 GlaxoSmithKline plc Company Information 13.2.2 GlaxoSmithKline plc Attenuated Vaccine Product Portfolios and Specifications 13.2.3 GlaxoSmithKline plc Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 GlaxoSmithKline plc Main Business Overview 13.2.5 GlaxoSmithKline plc Latest Developments 13.3 Pfizer Inc 13.3.1 Pfizer Inc Company Information 13.3.2 Pfizer Inc Attenuated Vaccine Product Portfolios and Specifications 13.3.3 Pfizer Inc Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 Pfizer Inc Main Business Overview 13.3.5 Pfizer Inc Latest Developments 13.4 Sanofi 13.4.1 Sanofi Company Information 13.4.2 Sanofi Attenuated Vaccine Product Portfolios and Specifications 13.4.3 Sanofi Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 Sanofi Main Business Overview 13.4.5 Sanofi Latest Developments 13.5 Astellas Pharma 13.5.1 Astellas Pharma Company Information 13.5.2 Astellas Pharma Attenuated Vaccine Product Portfolios and Specifications 13.5.3 Astellas Pharma Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 Astellas Pharma Main Business Overview 13.5.5 Astellas Pharma Latest Developments 13.6 Johnson & Johnson 13.6.1 Johnson & Johnson Company Information 13.6.2 Johnson & Johnson Attenuated Vaccine Product Portfolios and Specifications 13.6.3 Johnson & Johnson Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Johnson & Johnson Main Business Overview 13.6.5 Johnson & Johnson Latest Developments 13.7 CSL Limited 13.7.1 CSL Limited Company Information 13.7.2 CSL Limited Attenuated Vaccine Product Portfolios and Specifications 13.7.3 CSL Limited Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 CSL Limited Main Business Overview 13.7.5 CSL Limited Latest Developments 13.8 Serum Institute of India Pvt. Ltd. 13.8.1 Serum Institute of India Pvt. Ltd. Company Information 13.8.2 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product Portfolios and Specifications 13.8.3 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Serum Institute of India Pvt. Ltd. Main Business Overview 13.8.5 Serum Institute of India Pvt. Ltd. Latest Developments 13.9 Biken 13.9.1 Biken Company Information 13.9.2 Biken Attenuated Vaccine Product Portfolios and Specifications 13.9.3 Biken Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Biken Main Business Overview 13.9.5 Biken Latest Developments 13.10 Green Cross Corporation 13.10.1 Green Cross Corporation Company Information 13.10.2 Green Cross Corporation Attenuated Vaccine Product Portfolios and Specifications 13.10.3 Green Cross Corporation Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 Green Cross Corporation Main Business Overview 13.10.5 Green Cross Corporation Latest Developments 13.11 Shanghai Rongsheng Biotech 13.11.1 Shanghai Rongsheng Biotech Company Information 13.11.2 Shanghai Rongsheng Biotech Attenuated Vaccine Product Portfolios and Specifications 13.11.3 Shanghai Rongsheng Biotech Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.11.4 Shanghai Rongsheng Biotech Main Business Overview 13.11.5 Shanghai Rongsheng Biotech Latest Developments 13.12 Changchun BCHT Biotechnology Co.,Ltd 13.12.1 Changchun BCHT Biotechnology Co.,Ltd Company Information 13.12.2 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product Portfolios and Specifications 13.12.3 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.12.4 Changchun BCHT Biotechnology Co.,Ltd Main Business Overview 13.12.5 Changchun BCHT Biotechnology Co.,Ltd Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Attenuated Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. Attenuated Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Bacterial Vaccine Table 4. Major Players of Viral Vaccine Table 5. Global Attenuated Vaccine Sales by Type (2020-2025) & (K Doses) Table 6. Global Attenuated Vaccine Sales Market Share by Type (2020-2025) Table 7. Global Attenuated Vaccine Revenue by Type (2020-2025) & ($ million) Table 8. Global Attenuated Vaccine Revenue Market Share by Type (2020-2025) Table 9. Global Attenuated Vaccine Sale Price by Type (2020-2025) & (US$/Dose) Table 10. Global Attenuated Vaccine Sale by Application (2020-2025) & (K Doses) Table 11. Global Attenuated Vaccine Sale Market Share by Application (2020-2025) Table 12. Global Attenuated Vaccine Revenue by Application (2020-2025) & ($ million) Table 13. Global Attenuated Vaccine Revenue Market Share by Application (2020-2025) Table 14. Global Attenuated Vaccine Sale Price by Application (2020-2025) & (US$/Dose) Table 15. Global Attenuated Vaccine Sales by Company (2020-2025) & (K Doses) Table 16. Global Attenuated Vaccine Sales Market Share by Company (2020-2025) Table 17. Global Attenuated Vaccine Revenue by Company (2020-2025) & ($ millions) Table 18. Global Attenuated Vaccine Revenue Market Share by Company (2020-2025) Table 19. Global Attenuated Vaccine Sale Price by Company (2020-2025) & (US$/Dose) Table 20. Key Manufacturers Attenuated Vaccine Producing Area Distribution and Sales Area Table 21. Players Attenuated Vaccine Products Offered Table 22. Attenuated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global Attenuated Vaccine Sales by Geographic Region (2020-2025) & (K Doses) Table 26. Global Attenuated Vaccine Sales Market Share Geographic Region (2020-2025) Table 27. Global Attenuated Vaccine Revenue by Geographic Region (2020-2025) & ($ millions) Table 28. Global Attenuated Vaccine Revenue Market Share by Geographic Region (2020-2025) Table 29. Global Attenuated Vaccine Sales by Country/Region (2020-2025) & (K Doses) Table 30. Global Attenuated Vaccine Sales Market Share by Country/Region (2020-2025) Table 31. Global Attenuated Vaccine Revenue by Country/Region (2020-2025) & ($ millions) Table 32. Global Attenuated Vaccine Revenue Market Share by Country/Region (2020-2025) Table 33. Americas Attenuated Vaccine Sales by Country (2020-2025) & (K Doses) Table 34. Americas Attenuated Vaccine Sales Market Share by Country (2020-2025) Table 35. Americas Attenuated Vaccine Revenue by Country (2020-2025) & ($ millions) Table 36. Americas Attenuated Vaccine Sales by Type (2020-2025) & (K Doses) Table 37. Americas Attenuated Vaccine Sales by Application (2020-2025) & (K Doses) Table 38. APAC Attenuated Vaccine Sales by Region (2020-2025) & (K Doses) Table 39. APAC Attenuated Vaccine Sales Market Share by Region (2020-2025) Table 40. APAC Attenuated Vaccine Revenue by Region (2020-2025) & ($ millions) Table 41. APAC Attenuated Vaccine Sales by Type (2020-2025) & (K Doses) Table 42. APAC Attenuated Vaccine Sales by Application (2020-2025) & (K Doses) Table 43. Europe Attenuated Vaccine Sales by Country (2020-2025) & (K Doses) Table 44. Europe Attenuated Vaccine Revenue by Country (2020-2025) & ($ millions) Table 45. Europe Attenuated Vaccine Sales by Type (2020-2025) & (K Doses) Table 46. Europe Attenuated Vaccine Sales by Application (2020-2025) & (K Doses) Table 47. Middle East & Africa Attenuated Vaccine Sales by Country (2020-2025) & (K Doses) Table 48. Middle East & Africa Attenuated Vaccine Revenue Market Share by Country (2020-2025) Table 49. Middle East & Africa Attenuated Vaccine Sales by Type (2020-2025) & (K Doses) Table 50. Middle East & Africa Attenuated Vaccine Sales by Application (2020-2025) & (K Doses) Table 51. Key Market Drivers & Growth Opportunities of Attenuated Vaccine Table 52. Key Market Challenges & Risks of Attenuated Vaccine Table 53. Key Industry Trends of Attenuated Vaccine Table 54. Attenuated Vaccine Raw Material Table 55. Key Suppliers of Raw Materials Table 56. Attenuated Vaccine Distributors List Table 57. Attenuated Vaccine Customer List Table 58. Global Attenuated Vaccine Sales Forecast by Region (2026-2031) & (K Doses) Table 59. Global Attenuated Vaccine Revenue Forecast by Region (2026-2031) & ($ millions) Table 60. Americas Attenuated Vaccine Sales Forecast by Country (2026-2031) & (K Doses) Table 61. Americas Attenuated Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 62. APAC Attenuated Vaccine Sales Forecast by Region (2026-2031) & (K Doses) Table 63. APAC Attenuated Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 64. Europe Attenuated Vaccine Sales Forecast by Country (2026-2031) & (K Doses) Table 65. Europe Attenuated Vaccine Revenue Forecast by Country (2026-2031) & ($ millions) Table 66. Middle East & Africa Attenuated Vaccine Sales Forecast by Country (2026-2031) & (K Doses) Table 67. Middle East & Africa Attenuated Vaccine Revenue Forecast by Country (2026-2031) & ($ millions) Table 68. Global Attenuated Vaccine Sales Forecast by Type (2026-2031) & (K Doses) Table 69. Global Attenuated Vaccine Revenue Forecast by Type (2026-2031) & ($ millions) Table 70. Global Attenuated Vaccine Sales Forecast by Application (2026-2031) & (K Doses) Table 71. Global Attenuated Vaccine Revenue Forecast by Application (2026-2031) & ($ millions) Table 72. Merck & Co. Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 73. Merck & Co. Attenuated Vaccine Product Portfolios and Specifications Table 74. Merck & Co. Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 75. Merck & Co. Main Business Table 76. Merck & Co. Latest Developments Table 77. GlaxoSmithKline plc Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 78. GlaxoSmithKline plc Attenuated Vaccine Product Portfolios and Specifications Table 79. GlaxoSmithKline plc Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 80. GlaxoSmithKline plc Main Business Table 81. GlaxoSmithKline plc Latest Developments Table 82. Pfizer Inc Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 83. Pfizer Inc Attenuated Vaccine Product Portfolios and Specifications Table 84. Pfizer Inc Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 85. Pfizer Inc Main Business Table 86. Pfizer Inc Latest Developments Table 87. Sanofi Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 88. Sanofi Attenuated Vaccine Product Portfolios and Specifications Table 89. Sanofi Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 90. Sanofi Main Business Table 91. Sanofi Latest Developments Table 92. Astellas Pharma Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 93. Astellas Pharma Attenuated Vaccine Product Portfolios and Specifications Table 94. Astellas Pharma Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 95. Astellas Pharma Main Business Table 96. Astellas Pharma Latest Developments Table 97. Johnson & Johnson Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 98. Johnson & Johnson Attenuated Vaccine Product Portfolios and Specifications Table 99. Johnson & Johnson Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 100. Johnson & Johnson Main Business Table 101. Johnson & Johnson Latest Developments Table 102. CSL Limited Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 103. CSL Limited Attenuated Vaccine Product Portfolios and Specifications Table 104. CSL Limited Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 105. CSL Limited Main Business Table 106. CSL Limited Latest Developments Table 107. Serum Institute of India Pvt. Ltd. Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 108. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product Portfolios and Specifications Table 109. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 110. Serum Institute of India Pvt. Ltd. Main Business Table 111. Serum Institute of India Pvt. Ltd. Latest Developments Table 112. Biken Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 113. Biken Attenuated Vaccine Product Portfolios and Specifications Table 114. Biken Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 115. Biken Main Business Table 116. Biken Latest Developments Table 117. Green Cross Corporation Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 118. Green Cross Corporation Attenuated Vaccine Product Portfolios and Specifications Table 119. Green Cross Corporation Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 120. Green Cross Corporation Main Business Table 121. Green Cross Corporation Latest Developments Table 122. Shanghai Rongsheng Biotech Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 123. Shanghai Rongsheng Biotech Attenuated Vaccine Product Portfolios and Specifications Table 124. Shanghai Rongsheng Biotech Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 125. Shanghai Rongsheng Biotech Main Business Table 126. Shanghai Rongsheng Biotech Latest Developments Table 127. Changchun BCHT Biotechnology Co.,Ltd Basic Information, Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 128. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product Portfolios and Specifications Table 129. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025) Table 130. Changchun BCHT Biotechnology Co.,Ltd Main Business Table 131. Changchun BCHT Biotechnology Co.,Ltd Latest Developments List of Figures Figure 1. Picture of Attenuated Vaccine Figure 2. Attenuated Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Attenuated Vaccine Sales Growth Rate 2020-2031 (K Doses) Figure 7. Global Attenuated Vaccine Revenue Growth Rate 2020-2031 ($ millions) Figure 8. Attenuated Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. Attenuated Vaccine Sales Market Share by Country/Region (2024) Figure 10. Attenuated Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of Bacterial Vaccine Figure 12. Product Picture of Viral Vaccine Figure 13. Global Attenuated Vaccine Sales Market Share by Type in 2025 Figure 14. Global Attenuated Vaccine Revenue Market Share by Type (2020-2025) Figure 15. Attenuated Vaccine Consumed in Hospital Figure 16. Global Attenuated Vaccine Market: Hospital (2020-2025) & (K Doses) Figure 17. Attenuated Vaccine Consumed in Clinic Figure 18. Global Attenuated Vaccine Market: Clinic (2020-2025) & (K Doses) Figure 19. Attenuated Vaccine Consumed in Others Figure 20. Global Attenuated Vaccine Market: Others (2020-2025) & (K Doses) Figure 21. Global Attenuated Vaccine Sale Market Share by Application (2024) Figure 22. Global Attenuated Vaccine Revenue Market Share by Application in 2025 Figure 23. Attenuated Vaccine Sales by Company in 2025 (K Doses) Figure 24. Global Attenuated Vaccine Sales Market Share by Company in 2025 Figure 25. Attenuated Vaccine Revenue by Company in 2025 ($ millions) Figure 26. Global Attenuated Vaccine Revenue Market Share by Company in 2025 Figure 27. Global Attenuated Vaccine Sales Market Share by Geographic Region (2020-2025) Figure 28. Global Attenuated Vaccine Revenue Market Share by Geographic Region in 2025 Figure 29. Americas Attenuated Vaccine Sales 2020-2025 (K Doses) Figure 30. Americas Attenuated Vaccine Revenue 2020-2025 ($ millions) Figure 31. APAC Attenuated Vaccine Sales 2020-2025 (K Doses) Figure 32. APAC Attenuated Vaccine Revenue 2020-2025 ($ millions) Figure 33. Europe Attenuated Vaccine Sales 2020-2025 (K Doses) Figure 34. Europe Attenuated Vaccine Revenue 2020-2025 ($ millions) Figure 35. Middle East & Africa Attenuated Vaccine Sales 2020-2025 (K Doses) Figure 36. Middle East & Africa Attenuated Vaccine Revenue 2020-2025 ($ millions) Figure 37. Americas Attenuated Vaccine Sales Market Share by Country in 2025 Figure 38. Americas Attenuated Vaccine Revenue Market Share by Country (2020-2025) Figure 39. Americas Attenuated Vaccine Sales Market Share by Type (2020-2025) Figure 40. Americas Attenuated Vaccine Sales Market Share by Application (2020-2025) Figure 41. United States Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 42. Canada Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 43. Mexico Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 44. Brazil Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 45. APAC Attenuated Vaccine Sales Market Share by Region in 2025 Figure 46. APAC Attenuated Vaccine Revenue Market Share by Region (2020-2025) Figure 47. APAC Attenuated Vaccine Sales Market Share by Type (2020-2025) Figure 48. APAC Attenuated Vaccine Sales Market Share by Application (2020-2025) Figure 49. China Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 50. Japan Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 51. South Korea Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 52. Southeast Asia Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 53. India Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 54. Australia Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 55. China Taiwan Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 56. Europe Attenuated Vaccine Sales Market Share by Country in 2025 Figure 57. Europe Attenuated Vaccine Revenue Market Share by Country (2020-2025) Figure 58. Europe Attenuated Vaccine Sales Market Share by Type (2020-2025) Figure 59. Europe Attenuated Vaccine Sales Market Share by Application (2020-2025) Figure 60. Germany Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 61. France Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 62. UK Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 63. Italy Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 64. Russia Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 65. Middle East & Africa Attenuated Vaccine Sales Market Share by Country (2020-2025) Figure 66. Middle East & Africa Attenuated Vaccine Sales Market Share by Type (2020-2025) Figure 67. Middle East & Africa Attenuated Vaccine Sales Market Share by Application (2020-2025) Figure 68. Egypt Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 69. South Africa Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 70. Israel Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 71. Turkey Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 72. GCC Countries Attenuated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 73. Manufacturing Cost Structure Analysis of Attenuated Vaccine in 2025 Figure 74. Manufacturing Process Analysis of Attenuated Vaccine Figure 75. Industry Chain Structure of Attenuated Vaccine Figure 76. Channels of Distribution Figure 77. Global Attenuated Vaccine Sales Market Forecast by Region (2026-2031) Figure 78. Global Attenuated Vaccine Revenue Market Share Forecast by Region (2026-2031) Figure 79. Global Attenuated Vaccine Sales Market Share Forecast by Type (2026-2031) Figure 80. Global Attenuated Vaccine Revenue Market Share Forecast by Type (2026-2031) Figure 81. Global Attenuated Vaccine Sales Market Share Forecast by Application (2026-2031) Figure 82. Global Attenuated Vaccine Revenue Market Share Forecast by Application (2026-2031)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co.|||GlaxoSmithKline plc|||Pfizer Inc|||Sanofi|||Astellas Pharma|||Johnson & Johnson|||CSL Limited|||Serum Institute of India Pvt. Ltd.|||Biken|||Green Cross Corporation|||Shanghai Rongsheng Biotech|||Changchun BCHT Biotechnology Co.,Ltd